ABSTRACT
Folate metabolism is required for important biochemical processes that regulate cell functioning, but its role in female reproductive physiology in cattle during peri- and post-conceptional periods has not been thoroughly explored. Previous studies have shown the presence of folate in bovine oviductal fluid, as well as finely regulated gene expression of folate receptors and transporters in bovine oviduct epithelial cells (BOECs). Additionally, extracellular folic acid (FA) affects the transcriptional levels of genes important for the functioning of BOECs. However, it remains unknown whether the anatomical and cyclic features inherent to the oviduct affect regulation of folate metabolism. The present study aimed to characterize the gene expression pattern of folate cycle enzymes in BOECs from different anatomical regions during the estrous cycle and to determine the transcriptional response of these genes to increasing concentrations of exogenous FA. A first PCR screening showed the presence of transcripts encoding dihydrofolate reductase (DHFR), methylenetetrahydrofolate reductase (MTHFR), and methionine synthase (MTR) in bovine reproductive tissues (ovary, oviduct and uterus), with expression levels in oviductal tissues comparable to, or even higher than, those detected in ovarian and uterine tissues. Moreover, expression analysis through RT-qPCR in BOECs from the ampulla and isthmus during different stages of the estrous cycle demonstrated that folate metabolism-related enzymes exhibited cycle-dependent variations. In both anatomical regions, DHFR was upregulated during the preovulatory stage, while MTHFR and MTR exhibited increased expression levels during the postovulatory stage. Under in vitro culture conditions, ampullary and isthmic cells were cultured in the presence of 10, 50, and 100 µM FA for 24 h. Under these conditions, isthmus epithelial cells exhibited a unique transcriptional response to exogenous FA, showing a pronounced increase in MTR expression levels. Our results suggest that the expression of folate metabolism-related genes in BOECs is differentially regulated during the estrous cycle and may respond to exogenous levels of folate. This offers a new perspective on the transcriptional regulation of genes associated with the folate cycle in oviductal cells and provides groundwork for future studies on their functional and epigenetic implications within the oviductal microenvironment.
Subject(s)
Estrous Cycle , Folic Acid , Animals , Female , Cattle , Estrous Cycle/metabolism , Folic Acid/pharmacology , Folic Acid/metabolism , Fallopian Tubes/metabolism , Fallopian Tubes/drug effects , Oviducts/metabolism , Oviducts/drug effects , Tetrahydrofolate Dehydrogenase/genetics , Tetrahydrofolate Dehydrogenase/metabolism , Epithelial Cells/metabolism , Epithelial Cells/drug effects , Methylenetetrahydrofolate Reductase (NADPH2)/genetics , Methylenetetrahydrofolate Reductase (NADPH2)/metabolism , 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase/metabolism , 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase/genetics , Gene Expression Regulation/drug effects , Gene Expression Regulation, Enzymologic/drug effectsABSTRACT
Antifolates such as methotrexate (MTX) have been largely known as anticancer agents because of their role in blocking nucleic acid synthesis and cell proliferation. Their mechanism of action lies in their ability to inhibit enzymes involved in the folic acid cycle, especially human dihydrofolate reductase (hDHFR). However, most of them have a classical structure that has proven ineffective against melanoma, and, therefore, inhibitors with a non-classical lipophilic structure are increasingly becoming an attractive alternative to circumvent this clinical resistance. In this study, we conducted a protocol combining virtual screening (VS) and cell-based assays to identify new potential non-classical hDHFR inhibitors. Among 173 hit compounds identified (average logP = 3.68; average MW = 378.34 Da), two-herein, called C1 and C2-exhibited activity against melanoma cell lines B16 and A375 by MTT and Trypan-Blue assays. C1 showed cell growth arrest (39% and 56%) and C2 showed potent cytotoxic activity (77% and 51%) in a dose-dependent manner. The effects of C2 on A375 cell viability were greater than MTX (98% vs 60%) at equivalent concentrations and times. Our results indicate that the integrated in silico/in vitro approach provided a benchmark to identify novel promising non-classical DHFR inhibitors showing activity against melanoma cells.
Subject(s)
Antineoplastic Agents , Folic Acid Antagonists , Melanoma , Humans , Folic Acid Antagonists/pharmacology , Folic Acid Antagonists/chemistry , Tetrahydrofolate Dehydrogenase/metabolism , Antineoplastic Agents/pharmacology , Antineoplastic Agents/chemistry , Melanoma/drug therapy , Methotrexate/pharmacologyABSTRACT
Here we introduce zapalog-mediated endoplasmic reticulum trap (zapERtrap), which allows one to use light to precisely trigger forward trafficking of diverse integral membrane proteins from internal secretory organelles to the cell surface with single cell and subcellular spatial resolution. To demonstrate its utility, we use zapERtrap in neurons to dissect where synaptic proteins emerge at the cell surface when processed through central (cell body) or remote (dendrites) secretory pathways. We reveal rapid and direct long-range trafficking of centrally processed proteins deep into the dendritic arbor to synaptic sites. Select proteins were also trafficked to the plasma membrane of the axon initial segment, revealing a novel surface trafficking hotspot. Proteins locally processed through dendritic secretory networks were widely dispersed before surface insertion, challenging assumptions for precise trafficking at remote sites. These experiments provide new insights into compartmentalized secretory trafficking and showcase the tunability and spatiotemporal control of zapERtrap, which will have broad applications for regulating cell signaling and function.
Subject(s)
Cell Membrane/metabolism , Endoplasmic Reticulum/metabolism , Neurons/metabolism , Secretory Pathway/genetics , Synapses/metabolism , Synaptic Transmission/genetics , Animals , Animals, Newborn , Cell Adhesion Molecules, Neuronal/genetics , Cell Adhesion Molecules, Neuronal/metabolism , Cell Membrane/ultrastructure , Endoplasmic Reticulum/ultrastructure , Female , Fluorescent Dyes/chemistry , Gene Expression , Golgi Apparatus/metabolism , Golgi Apparatus/ultrastructure , Hippocampus/cytology , Hippocampus/metabolism , Light , Male , Molecular Imaging/methods , Neurons/cytology , Primary Cell Culture , Protein Transport , Rats , Rats, Sprague-Dawley , Receptors, AMPA/genetics , Receptors, AMPA/metabolism , Synapses/ultrastructure , Tacrolimus Binding Proteins/genetics , Tacrolimus Binding Proteins/metabolism , Tetrahydrofolate Dehydrogenase/genetics , Tetrahydrofolate Dehydrogenase/metabolismABSTRACT
In medicinal chemistry, it is extremely important to evaluate, as accurately as possible, the molecular interactions involved in the formation of different ligand-receptor (L-R) complexes. Evaluating the different molecular interactions by quantum mechanics calculations is not a simple task, since formation of an L-R complex is a dynamic process. In this case, the use of combined techniques of molecular dynamics (MD) and quantum calculations is one the best possible approaches. In this work we report a comparative study using combined MD and QTAIM (Quantum Theory of Atoms In Molecules) calculations for five biological systems with different levels of structural complexity. We have studied Acetylcholinesterase (AChE), D2 Dopamine Receptor (D2DR), beta Secretase (BACE1), Dihydrofolate Reductase (DHFR) and Sphingosine Kinase 1 (SphK1). In these molecular targets, we have analyzed different ligands with diverse structural characteristics. The inhibitory activities of most of them have been previously measured in our laboratory. Our results indicate that QTAIM calculations can be extremely useful for in silico studies. It is possible to obtain very accurate information about the strength of the molecular interactions that stabilize the formation of the different L-R complexes. Better correlations can be obtained between theoretical and experimental data by using QTAIM calculations, allowing us to discriminate among ligands with similar affinities. QTAIM analysis gives fairly accurate information for weak interactions which are not well described by MD simulations. QTAIM study also allowed us to evaluate and determine which parts of the ligand need to be modified in order to increase its interactions with the molecular target. In this study we have discussed the importance of combined MD/QTAIM calculations for this type of simulations, showing their scopes and limitations.
Subject(s)
Acetylcholinesterase/metabolism , Amyloid Precursor Protein Secretases/metabolism , Phosphotransferases (Alcohol Group Acceptor)/metabolism , Receptors, Dopamine D2/metabolism , Tetrahydrofolate Dehydrogenase/metabolism , Acetylcholinesterase/chemistry , Amyloid Precursor Protein Secretases/chemistry , Ligands , Models, Chemical , Molecular Docking Simulation , Molecular Dynamics Simulation , Phosphotransferases (Alcohol Group Acceptor)/chemistry , Quantum Theory , Receptors, Dopamine D2/chemistry , Tetrahydrofolate Dehydrogenase/chemistry , ThermodynamicsABSTRACT
Sulfonamides have been in clinical use for many years, and the development of bioactive substances containing the sulfonamide subunit has grown steadily in view of their important biological properties such as antibacterial, antifungal, antiparasitic, antioxidant, and antitumour properties. This review addresses the medicinal chemistry aspects of sulfonamides; covering their discovery, the structure- activity relationship and the mechanism of action of the antibacterial sulfonamide class, as well as the physico-chemical and pharmacological properties associated with this class. It also provides an overview of the various biological activities inherent to sulfonamides, reporting research that emphasises the importance of this group in the planning and development of bioactive substances, with a special focus on potential antitumour properties. The synthesis of sulfonamides is considered to be simple and provides a diversity of derivatives from a wide variety of amines and sulfonyl chlorides. The sulfonamide group is a non-classical bioisostere of carboxyl groups, phenolic hydroxyl groups and amide groups. This review highlights that most of the bioactive substances have the sulfonamide group, or a related group such as sulfonylurea, in an orientation towards other functional groups. This structural characteristic was observed in molecules with distinct antibacterial activities, demonstrating a clear structure-activity relationship of sulfonamides. This short review sought to contextualise the discovery of classic antibacterial sulfonamides and their physico-chemical and pharmacological properties. The importance of the sulfonamide subunit in Medicinal Chemistry has been highlighted and emphasised, in order to promote its inclusion in the planning and synthesis of future drugs.
Subject(s)
Anti-Bacterial Agents/chemistry , Antineoplastic Agents/chemistry , Sulfonamides/chemistry , Actinobacillus/drug effects , Anti-Bacterial Agents/metabolism , Anti-Bacterial Agents/pharmacology , Antineoplastic Agents/metabolism , Antineoplastic Agents/pharmacology , Cell Survival/drug effects , Humans , Structure-Activity Relationship , Sulfonamides/metabolism , Sulfonamides/pharmacology , Tetrahydrofolate Dehydrogenase/chemistry , Tetrahydrofolate Dehydrogenase/metabolismABSTRACT
Dihydrofolate reductase (DHFR) is an essential enzyme for nucleotide metabolism used to obtain energy and structural nucleic acids. Schistosoma mansoni has all the pathways for pyrimidine biosynthesis, which include the thymidylate cycle and, consequentially, the DHFR enzyme. Here, we describe the characterization of Schistosoma mansoni DHFR (SmDHFR) using isothermal titration calorimetry for the enzymatic activity and thermodynamic determination, also the folate analogs inhibition. Moreover, X-ray crystallography was used to determine the enzyme atomic model at 1.95 Å.
Subject(s)
Schistosoma mansoni/enzymology , Tetrahydrofolate Dehydrogenase/metabolism , Animals , Calorimetry , Crystallography, X-Ray , Enzyme Assays , Folic Acid/analogs & derivatives , Freezing , Recombinant Proteins/isolation & purification , Recombinant Proteins/metabolism , Synchrotrons , Tetrahydrofolate Dehydrogenase/chemistry , Tetrahydrofolate Dehydrogenase/genetics , Tetrahydrofolate Dehydrogenase/isolation & purificationABSTRACT
Leishmaniasis is a tropical disease found in more than 90 countries. The drugs available to treat this disease have nonspecific action and high toxicity. In order to develop novel therapeutic alternatives to fight this ailment, pteridine reductase 1 (PTR1) and dihydrofolate reductase-thymidylate synthase (DHF-TS) have been targeted, once Leishmania is auxotrophic for folates. Although PTR1 and DHFR-TS from other protozoan parasites have been studied, their homologs in Leishmania chagasi have been poorly characterized. Hence, this work describes the optimal conditions to express the recombinant LcPTR1 and LcDHFR-TS enzymes, as well as balanced assay conditions for screening. Last but not the least, we show that 2,4 diaminopyrimidine derivatives are low-micromolar competitive inhibitors of both enzymes (LcPTR1 Ki = 1.50-2.30 µM and LcDHFR Ki = 0.28-3.00 µM) with poor selectivity index. On the other hand, compound 5 (2,4-diaminoquinazoline derivative) is a selective LcPTR1 inhibitor (Ki = 0.47 µM, selectivity index = 20).
Subject(s)
Enzyme Inhibitors/pharmacology , Leishmania infantum/enzymology , Multienzyme Complexes/antagonists & inhibitors , Oxidoreductases/antagonists & inhibitors , Thymidylate Synthase/antagonists & inhibitors , Catalysis , Chromatography, Affinity , Cloning, Molecular , Drug Evaluation, Preclinical , Electrophoresis, Polyacrylamide Gel , Escherichia coli/genetics , Inhibitory Concentration 50 , Multienzyme Complexes/genetics , Multienzyme Complexes/isolation & purification , Multienzyme Complexes/metabolism , Oxidoreductases/genetics , Oxidoreductases/isolation & purification , Oxidoreductases/metabolism , Tetrahydrofolate Dehydrogenase/genetics , Tetrahydrofolate Dehydrogenase/isolation & purification , Tetrahydrofolate Dehydrogenase/metabolism , Thymidylate Synthase/genetics , Thymidylate Synthase/isolation & purification , Thymidylate Synthase/metabolismABSTRACT
Leishmaniasis is one of the major neglected tropical diseases in the world and it is considered endemic in 88 countries. This disease is transmitted by a Leishmania spp. infected sandfly and it may lead to cutaneous or systemic manifestations. The preconized treatment has low efficacy and there are cases of resistance to some drugs. Therefore, the search for new efficient molecular targets that can lead to the preparation of new drugs must be pursued. This review aims to evaluate both Leishmania enzymes PTR1 and DHFR-TS as potential drug targets, highlight their inhibitors and to discuss critically the use of chemoinformatics to elucidate interactions and propose new molecules against these enzymes.
Subject(s)
Antiprotozoal Agents/pharmacology , Folic Acid Antagonists/pharmacology , Leishmania/drug effects , Leishmania/enzymology , Multienzyme Complexes/antagonists & inhibitors , Oxidoreductases/antagonists & inhibitors , Thymidylate Synthase/antagonists & inhibitors , Animals , Antiprotozoal Agents/chemistry , Antiprotozoal Agents/therapeutic use , Drug Discovery , Folic Acid Antagonists/chemistry , Folic Acid Antagonists/therapeutic use , Humans , Leishmania/metabolism , Leishmaniasis/drug therapy , Leishmaniasis/parasitology , Molecular Targeted Therapy , Multienzyme Complexes/metabolism , Oxidoreductases/metabolism , Tetrahydrofolate Dehydrogenase/metabolism , Thymidylate Synthase/metabolismSubject(s)
Anti-Infective Agents/pharmacology , Antimalarials/pharmacology , Drug Discovery , Enzyme Inhibitors/pharmacology , Neglected Diseases/drug therapy , Trypanocidal Agents/pharmacology , Animals , Anti-Infective Agents/chemical synthesis , Anti-Infective Agents/chemistry , Antimalarials/chemical synthesis , Antimalarials/chemistry , Enzyme Inhibitors/chemical synthesis , Enzyme Inhibitors/chemistry , Fatty Acids/chemical synthesis , Fatty Acids/chemistry , Fatty Acids/pharmacology , Fructose-Bisphosphate Aldolase/antagonists & inhibitors , Fructose-Bisphosphate Aldolase/metabolism , Humans , Models, Molecular , Plasmodium/drug effects , Polyamines/chemical synthesis , Polyamines/chemistry , Polyamines/pharmacology , Schistosoma mansoni/enzymology , Tetrahydrofolate Dehydrogenase/metabolism , Trypanocidal Agents/chemical synthesis , Trypanocidal Agents/chemistry , Trypanosoma brucei brucei/enzymology , Ubiquitin-Protein Ligases/antagonists & inhibitors , Ubiquitin-Protein Ligases/metabolismABSTRACT
INTRODUCTION: Schistosoma mansoni is responsible for virtually all reported cases of schistosomiasis in Latin America and the emergence of praziquantel- and oxaminiquine-resistant strains makes it urgent to develop new schistosomicide agents. Dihydrofolate reductases (DHFR) from bacteria and protozoan parasites are considered validated macromolecular targets for this goal, but S. mansoni DHFR (SmDHFR) has been largely overlooked. To fill this gap in knowledge, the present work describes optimized conditions to carry out thermal shift assays with SmDHFR, as well as a balanced kinetic assay that supports 2,4-diaminopyrimidine derivatives as SmDHFR inhibitors. The most potent inhibitor (2a) shows a large shift of the melting temperature (ΔTm = + 8 ± 0,21 ºC) and a low micromolar IC50 value (12 ± 2,3 µM). Both thermal shift and classical kinectic assay suggest that 2a binds to the substrate binding site (competitive inhibition mechanism). This information guided docking and molecular dynamics studies that probed 2a interaction profile towards SmDHFR. CONCLUSION: In conclusion, this work not only provides standardized assay conditions to identify SmDHFR inhibitors, but also describes the binding profile of the first low micromolar inhibitor of this macromolecular target.
Subject(s)
Folic Acid Antagonists/analysis , Folic Acid Antagonists/chemistry , Models, Molecular , Pyrimidines/pharmacology , Schistosoma mansoni/drug effects , Schistosoma mansoni/enzymology , Tetrahydrofolate Dehydrogenase/metabolism , Animals , Crystallography, X-Ray , Dose-Response Relationship, Drug , Folic Acid Antagonists/chemical synthesis , Folic Acid Antagonists/pharmacology , Molecular Structure , Pyrimidines/chemical synthesis , Pyrimidines/chemistry , Recombinant Proteins/metabolism , Structure-Activity RelationshipABSTRACT
Toxoplasmosis is a zoonosis of worldwide distribution. Currently, two drugs, pyrimethamine and sulfadiazine, are used as a reference in the treatment of toxoplasmosis, but the resistance of Toxoplasma gondii appears as a relevant public health problem. In order to identify new drugs to toxoplasmosis treatment, we performed a molecular docking of raltitrexed to T. gondii thymidylate synthase-dihydrofolate reductase (TS-DHFR) and also evaluated its efficacy in infected mice. Initially, raltitrexed was docked on the crystallographic structures of TS-DHFR from T. gondii and Mus musculus. Then, 48 h after infection with the T. gondii RH strain, different groups of mice received an oral dose of raltitrexed (0.15, 0.75, and 1.5 mg kg-1). Two days after treatments, raltitrexed was able to prevent mortality and reduce the number of tachyzoites in the peritoneal fluid and liver imprints from infected mice. The results showed that raltitrexed has important protective activities against the T. gondii RH strain. Molecular docking still suggests that the effects against the parasite may be dependent on the inhibition of T. gondii thymidylate synthase. This study opens new perspectives for the use of raltitrexed in patients infected with T. gondii, especially when conventional treatments do not exhibit the expected efficacy.
Subject(s)
Antimetabolites, Antineoplastic/pharmacology , Multienzyme Complexes/antagonists & inhibitors , Quinazolines/metabolism , Quinazolines/pharmacology , Thiophenes/metabolism , Thiophenes/pharmacology , Thymidylate Synthase/antagonists & inhibitors , Toxoplasma/drug effects , Toxoplasmosis, Animal/drug therapy , Animals , Humans , Male , Mice , Molecular Docking Simulation , Multienzyme Complexes/metabolism , Tetrahydrofolate Dehydrogenase/metabolism , Thymidylate Synthase/metabolism , Toxoplasma/enzymology , Toxoplasmosis, Animal/parasitologyABSTRACT
Background: The effects of high-dose folic acid (FA) supplementation in healthy individuals on blood folate concentrations and immune response are unknown.Objective: The aim of the study was to evaluate the effects of daily consumption of a tablet containing 5 mg FA on serum folate; number and cytotoxicity of natural killer (NK) cells; mRNA expression of dihydrofolate reductase (DHFR), methylenetetrahydrofolate reductase (MTHFR), interferon γ (IFNG), tumor necrosis factor α (TNFA), and interleukin 8 (IL8) genes; and concentrations of serum inflammatory markers.Methods: This prospective clinical trial was conducted in 30 healthy Brazilian adults (15 women), aged 27.7 y (95% CI: 26.4, 29.1 y), with a body mass index (in kg/m2) of 23.1 (95% CI: 22.0, 24.3). Blood was collected at baseline and after 45 and 90 d of the intervention. Serum folate concentrations were measured by microbiological assay and HPLC-tandem mass spectrometry [folate forms, including unmetabolized folic acid (UMFA)]. We used real-time polymerase chain reaction to assess mononuclear leukocyte mRNA expression and flow cytometry to measure the number and cytotoxicity of NK cells.Results: Serum folate concentrations increased by â¼5-fold after the intervention (P < 0.001), and UMFA concentrations increased by 11.9- and 5.9-fold at 45 and 90 d, respectively, when compared with baseline (P < 0.001). UMFA concentrations increased (>1.12 nmol/L) in 29 (96.6%) participants at day 45 and in 26 (86.7%) participants at day 90. We observed significant reductions in the number (P < 0.001) and cytotoxicity (P = 0.003) of NK cells after 45 and 90 d. Compared with baseline, DHFR mRNA expression was higher at 90 d (P = 0.006) and IL8 and TNFA mRNA expressions were higher at 45 and 90 d (P = 0.001 for both).Conclusion: This noncontrolled intervention showed that healthy adults responded to a high-dose FA supplement with increased UMFA concentrations, changes in cytokine mRNA expression, and reduced number and cytotoxicity of NK cells. This trial was registered at www.ensaiosclinicos.gov.br as RBR-2pr7zp.
Subject(s)
Dietary Supplements/adverse effects , Folic Acid/adverse effects , Inflammation Mediators/blood , Interleukin-8/blood , Killer Cells, Natural , Tumor Necrosis Factor-alpha/blood , Adult , Brazil , Female , Folic Acid/administration & dosage , Folic Acid/blood , Humans , Immunity/drug effects , Male , Methylenetetrahydrofolate Reductase (NADPH2)/genetics , Methylenetetrahydrofolate Reductase (NADPH2)/metabolism , Nutritional Status , Prospective Studies , RNA, Messenger/metabolism , Real-Time Polymerase Chain Reaction , Reference Values , Tetrahydrofolate Dehydrogenase/genetics , Tetrahydrofolate Dehydrogenase/metabolism , Tumor Necrosis Factor-alpha/genetics , Vitamin B Complex/administration & dosage , Vitamin B Complex/adverse effects , Vitamin B Complex/bloodABSTRACT
Targeted regulation of protein levels is an important tool to investigate the role of proteins essential for cell function and development. In recent years, methods based on the Escherichia coli dihydrofolate reductase destabilization domain (ecDHFR DD) have been established and used in various cell types. ecDHFR DD destabilizes the fused protein of interest and causes its degradation by proteasomes, unless it is stabilized by a specific ligand, trimethoprim. In this work we developed an inducible protein stabilization system in Leishmania mexicana based on ecDHFR DD.
Subject(s)
Gene Expression Regulation , Leishmania mexicana/genetics , Leishmania mexicana/metabolism , Molecular Biology/methods , Parasitology/methods , Transcriptional Activation , Escherichia coli/enzymology , Escherichia coli/genetics , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Tetrahydrofolate Dehydrogenase/genetics , Tetrahydrofolate Dehydrogenase/metabolism , Trimethoprim/metabolismABSTRACT
The parasite Schistosoma mansoni possesses all pathways for pyrimidine biosynthesis, in which dihydrofolate reductase (DHFR), thymidylate cycle participants, is essential for nucleotide metabolism to obtain energy and structural nucleic acids. Thus, DHFRs have been widely suggested as therapeutic targets for the treatment of infectious diseases. In this study, we expressed recombinant SmDHFR in a heterologous manner to obtain structural, biochemical and kinetic information. X-ray diffraction of recombinant SmDHFR at 1.95Å resolution showed that the structure exhibited the canonical DHFR fold. Isothermal titration calorimetry was used to determine the kinetic constants for NADP+ and dihydrofolate. Moreover, inhibition assays were performed using the commercial folate analogs methotrexate and aminopterin; these analogs are recognized as folate competitors and are used as chemotherapeutic agents in cancer and autoimmune diseases. This study provides information that may prove useful for the future discovery of novel drugs and for understanding these metabolic steps from this pathway of S. mansoni, thus aiding in our understanding of the function of these essential pathways for parasite metabolism.
Subject(s)
Schistosoma mansoni/enzymology , Tetrahydrofolate Dehydrogenase/chemistry , Tetrahydrofolate Dehydrogenase/metabolism , Animals , Folic Acid Antagonists/pharmacology , Humans , Kinetics , Methotrexate/pharmacology , Recombinant Proteins , X-Ray DiffractionABSTRACT
Coxiella burnetii is a gram-negative bacterium able to infect several eukaryotic cells, mainly monocytes and macrophages. It is found widely in nature with ticks, birds, and mammals as major hosts. C. burnetii is also the biological warfare agent that causes Q fever, a disease that has no vaccine or proven chemotherapy available. Considering the current geopolitical context, this fact reinforces the need for discovering new treatments and molecular targets for drug design against C. burnetii. Among the main molecular targets against bacterial diseases reported, the enzyme dihydrofolate reductase (DHFR) has been investigated for several infectious diseases. In the present work, we applied molecular modeling techniques to evaluate the interactions of known DHFR inhibitors in the active sites of human and C. burnetii DHFR (HssDHFR and CbDHFR) in order to investigate their potential as selective inhibitors of CbDHFR. Results showed that most of the ligands studied compete for the binding site of the substrate more effectively than the reference drug trimethoprim. Also the most promising compounds were proposed as leads for the drug design of potential CbDHFR inhibitors.
Subject(s)
Bacterial Proteins/antagonists & inhibitors , Coxiella burnetii/drug effects , Coxiella burnetii/metabolism , Folic Acid Antagonists/chemistry , Folic Acid Antagonists/pharmacology , Tetrahydrofolate Dehydrogenase/chemistry , Tetrahydrofolate Dehydrogenase/metabolism , Catalytic Domain , Drug Design , Humans , Ligands , Molecular Dynamics SimulationABSTRACT
BACKGROUND: Folate status has been positively associated with cognitive function in many studies; however, some studies have observed associations of poor cognitive outcomes with high folate. In search of an explanation, we hypothesized that the association of folate with cognition would be modified by the interaction of high-folate status with a common 19-bp deletion polymorphism in the dihydrofolate reductase (DHFR) gene. To our knowledge, the cognitive effects of this gene have not been studied previously. OBJECTIVE: We examined the association between cognitive outcomes with the 19-bp deletion DHFR polymorphism, folate status, and their interaction with high or normal plasma folate. DESIGN: This was a pooled cross-sectional study of the following 2 Boston-based cohorts of community living adults: the Boston Puerto Rican Health Study and the Nutrition, Aging, and Memory in Elders study. Individuals were genotyped for the DHFR 19-bp deletion genotype, and plasma folate status was determined. Cognitive outcomes included the Mini-Mental State Examination, Center for Epidemiologic Studies Depression Scale, and factor scores for the domains of memory, executive function, and attention from a set of cognitive tests. RESULTS: The prevalence of the homozygous deletion (del/del) genotype was 23%. In a multivariable analysis, high folate status (>17.8 ng/mL) was associated with better memory scores than was normal-folate status (fourth-fifth quintiles compared with first-third quintiles: ß ± SE = -0.22 ± 0.06, P < 0.01). Carriers of the DHFR del/del genotype had worse memory scores (ß ± SE = -0.24 ± 0.10, P < 0.05) and worse executive scores (ß = -0.19, P < 0.05) than did those with the del/ins and ins/ins genotypes. Finally, we observed an interaction such that carriers of the del/del genotype with high folate had significantly worse memory scores than those of both noncarriers with high-folate and del/del carriers with normal-folate (ß-interaction = 0.26 ± 0.13, P < 0.05). CONCLUSIONS: This study identifies a putative gene-nutrient interaction that, if confirmed, would predict that a sizable minority carrying the del/del genotype might not benefit from high-folate status and could see a worsening of memory. An understanding of how genetic variation affects responses to high-folate exposure will help weigh risks and benefits of folate supplementation for individuals and public health.
Subject(s)
Folic Acid Deficiency/genetics , Gene Deletion , Memory Disorders/etiology , Nutritional Status , Polymorphism, Genetic , Tetrahydrofolate Dehydrogenase/genetics , Black or African American , Aged , Aged, 80 and over , Boston/epidemiology , Cohort Studies , Cross-Sectional Studies , Female , Folic Acid/poisoning , Folic Acid Deficiency/enzymology , Folic Acid Deficiency/physiopathology , Genetic Association Studies , Hispanic or Latino , Humans , Male , Memory Disorders/epidemiology , Middle Aged , Nutrigenomics/methods , Prevalence , Puerto Rico/ethnology , Tetrahydrofolate Dehydrogenase/metabolism , White PeopleABSTRACT
In this study, four methods for sampling free-living ticks that are used in ecological and human tick-bite risk studies were evaluated. Cloth dragging, carbon dioxide traps and visual searches and inspection of plant litter on the ground were used in field and forest areas within the Brazilian Pantanal. Among the three tick species collected, Amblyomma sculptum predominated, followed by Amblyomma parvum and Amblyomma ovale. Dragging, a cheap and simple technique, yielded the highest numbers of ticks, particularly nymphs. The visual search detected a high number of adult ticks and provided information on tick questing height. Even though laborious, plant litter examination showed that large numbers of ticks may use this stratum. Carbon dioxide (CO2) traps are expensive and difficult to handle, but they are highly efficient for adult ticks, especially A. parvum. These data indicate that one method alone is incapable of providing a representative sample of the tick fauna in a particular area and that multiple techniques should be used for tick population studies.
Neste estudo, foram avaliados quatro métodos de amostragem de carrapatos em vida livre, usados em estudos ecológicos e avaliação do risco de picadas em humanos. Arraste de flanela, armadilhas de gás carbônico (CO2), busca visual e inspeção de serrapilheira foram aplicados em áreas campestres e florestais no Pantanal brasileiro. Dentre três espécies coletadas, a predominância foi de Amblyomma sculptum, seguida por Amblyomma parvum e Amblyomma ovale. O arraste, técnica simples e de baixo custo, resultou em maior número de carrapatos, particularmente de ninfas. A busca visual detectou alto número de carrapatos adultos e forneceu informações sobre altura de espera por hospedeiros. Apesar de trabalhoso, o exame da serrapilheira demonstrou que grande número de carrapatos pode utilizar esse estrato. Armadilhas de CO2 têm custo elevado e são difíceis de manusear, entretanto, são altamente eficientes para carrapatos adultos, em especial para A. parvum. Esses dados indicam que somente um método é incapaz de fornecer amostra representativa da ixodofauna em uma área particular e que, para estudos populacionais, técnicas múltiplas devem ser usadas.
Subject(s)
Animals , Humans , Tetrahydrofolate Dehydrogenase/chemistry , Amino Acid Sequence , Catalytic Domain , Crystallography, X-Ray , Folic Acid Antagonists/chemistry , Hydrogen Bonding , In Vitro Techniques , Macromolecular Substances , Models, Molecular , Molecular Sequence Data , NADP , Protein Conformation , Pyrimidines/chemistry , Recombinant Proteins/chemistry , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Sequence Homology, Amino Acid , Tetrahydrofolate Dehydrogenase/genetics , Tetrahydrofolate Dehydrogenase/metabolism , Toxoplasma/enzymologyABSTRACT
Recupera a atuação do antropólogo Charles Wagley como alto funcionário do Serviço Especial de Saúde Pública, programa de cooperação estabelecido entre EUA e Brasil na Segunda Guerra Mundial. Convocado a colaborar nos esforços de guerra, atuou na política de migração do Programa da Borracha. À luz dessa experiência de intervenção, do contexto marcado pela promoção do desenvolvimento e por questões então prementes no campo da antropologia, este estudo propõe-se retomar a obra Uma comunidade amazônica. Trata-se de discutir o estudo de comunidade conduzido na localidade amazônica que Wagley conheceu ainda durante as missões do Serviço e cuja realidade considerou ilustrativa de uma região subdesenvolvida, levando-o a refletir sobre mudança social e o papel das ciências.
The article focuses on the work of Charles Wagley as a top staff member with Serviço Especial de Saúde Pública (Special Public Health Service), a US-Brazil cooperation program established during World War II. Taking into consideration Wagley’s experience with migration policy under Brazil’s Rubber Program, as well as the context of development promotion and the issues then on the anthropological agenda, the article explores Wagley’s community study of the Amazon town he visited while on SESP missions, published in the book Uma comunidade amazônica (Amazon Town). Encountering a reality that he believed emblematic of underdevelopment, Wagley was led to reflect on social change and the role of science.
Subject(s)
Animals , Humans , Mice , Rats , Folic Acid Antagonists/chemical synthesis , Pyrimidines/chemistry , Tetrahydrofolate Dehydrogenase/metabolism , AIDS-Related Opportunistic Infections/drug therapy , Folic Acid Antagonists/pharmacology , Liver/enzymology , Pneumocystis , Pyrimidines/chemical synthesis , Pyrimidines/pharmacology , Toxoplasma , Trimetrexate/pharmacologyABSTRACT
Neospora caninum is an obligate intracellular Apicomplexa, a phylum where one of the current methods for functional studies relies on molecular genetic tools. For Toxoplasma gondii, the first method described, in 1993, was based on resistance against chloramphenicol. As in T. gondii, we developed a vector constituted of the chloramphenicol acetyltransferase gene (CAT) flanked by the N. caninum dihydrofolate reductase-thymidylate synthase (DHFR-TS) 5' coding sequence flanking region. Five weeks after transfection and under the selection of chloramphenicol the expression of CAT increased compared to the wild type and the resistance was retained for more than one year. Between the stop codon of CAT and the 3' UTR of DHFR, a Lac-Z gene controlled by the N. caninum tubulin 5' coding sequence flanking region was ligated, resulting in a vector with a reporter gene (Ncdhfr-CAT/NcTub-tetO/Lac-Z). The stability was maintained through an episomal pattern for 14 months when the tachyzoites succumbed, which was an unexpected phenomenon compared to T. gondii. Stable parasites expressing the Lac-Z gene allowed the detection of tachyzoites after invasion by enzymatic reaction (CPRG) and were visualised macro- and microscopically by X-Gal precipitation and fluorescence. This work developed the first vector for stable expression of proteins based on chloramphenicol resistance and controlled exclusively by N. caninum promoters.
Subject(s)
Chloramphenicol O-Acetyltransferase/genetics , Genetic Vectors/genetics , Neospora/genetics , Chloramphenicol O-Acetyltransferase/metabolism , Coccidiosis/parasitology , Genes, Reporter , Genetic Vectors/metabolism , Humans , Multienzyme Complexes/genetics , Multienzyme Complexes/metabolism , Neospora/growth & development , Neospora/metabolism , Tetrahydrofolate Dehydrogenase/genetics , Tetrahydrofolate Dehydrogenase/metabolism , Thymidylate Synthase/genetics , Thymidylate Synthase/metabolism , Toxoplasma/genetics , Toxoplasma/metabolismABSTRACT
A molecular modeling study on dihydrofolate reductase (DHFR) inhibitors was carried out. By combining molecular dynamics simulations with semiempirical (PM6), ab initio, and density functional theory (DFT) calculations, a simple and generally applicable procedure to evaluate the binding energies of DHFR inhibitors interacting with the human enzyme is reported here, providing a clear picture of the binding interactions of these ligands from both structural and energetic viewpoints. A reduced model for the binding pocket was used. This approach allows us to perform more accurate quantum mechanical calculations as well as to obtain a detailed electronic analysis using the quantum theory of atoms in molecules (QTAIM) technique. Thus, molecular aspects of the binding interactions between inhibitors and the DHFR are discussed in detail. A significant correlation between binding energies obtained from DFT calculations and experimental IC50 values was obtained, predicting with an acceptable qualitative accuracy the potential inhibitor effect of nonsynthesized compounds. Such correlation was experimentally corroborated synthesizing and testing two new inhibitors reported in this paper.